ADVI and American Cancer Society Cancer Action Network Discuss IRA Impacts

ADVI experts Lindsay Bealor Greenleaf, vice president and head of policy, and Brenna Raines, director of policy and reimbursement, joined the American Cancer Society Cancer Action Network’s webinar on September 26, titled, Rx Negotiation: The Potential Impact on Cancer Patients. In this webinar, the team discussed some of the key provisions of the Inflation Reduction Act (IRA) including Part D redesign, government negotiation, and the potential impact of the IRA on key stakeholders.

Listen in Here – ACS CAN Inflation Reduction Act Rx Negotiation: The Potential Impact on Cancer Patients Webinar

 

ADVI Team

Lindsay Bealor Greenleaf, JD, MBA

Solution Leader, Federal and State Policy

Brenna Raines

Senior Director

Further Resources:

ADVI insights

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Solution Leader, Federal and State Policy

ADVI Instant: CMS Releases 2025 OPPS Proposed Rule

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Solution Leader, Federal and State Policy

ADVI Instant: CMS Releases 2025 Physician Fee Schedule and Proposed Rule  

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Solution Leader, Federal and State Policy

ADVI Instant: CMS Releases CY 2025 ESRD PPS Proposed Rule
Sarah Butler

Insights,

| Sarah Butler - Chief Commercial Officer

Sarah Butler Discusses IRA and Commercial Strategy With ConnectiveRx